Pregnancy-Induced Sweet's Syndrome Treated with Infliximab

Conclusion: The "off -label" use of infliximab is beneficial for relapsing and resistant Sweet's syndrome.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research